Navigation Links
Successful PCR amplification and subcloning of a GC-rich DNA fragment

Petra Majlingov, Paolo Paroncini, Silvia Svegliati, Michele Luchetti, and Armando Gabrielli
Laboratorio di Medicina Molecolare, Istituto di Clinica Medica, Polo Didattico Scientifico, Ancona, Italy

The formation of robust secondary structures that resist denaturation makes GC-rich sequences difficult to amplify by PCR. This article demonstrates how a "difficult" GC-rich sequence was successfully amplified using HotStarTaq DNA Polymerase and Q-Solution. The PCR product was then ligated into the pDrive Cloning Vector, which was used to transform QIAGEN EZ Competent Cells with high efficiency.

Our group has been working for many years on the regulation of expression of the myb family of transcription factors (13). The myb gene family is made up of three genes, c-myb, A-myb, and B-myb, whose pattern of expression is controlled by complex mechanisms. For example, c-myb expression is regulated by a mechanism of transcriptional block in the first intron and alternative splicing.

In order to further investigate the role of the c-myb intron in expression, we attempted to amplify the Myb-INT gene fragment. Myb-INT is a 4500 bp DNA fragment from the first c-myb intron, and has a GC content of about 60%. Sequences that contain a high ratio of guanosine and cytidine base pairs (GC-rich sequences) can form robust secondary structures that resist denaturation and prevent annealing of PCR primers.

PCR was performed using HotStarTaq DNA Polymerase and 4 other commercially available DNA polymerases. Of the 5 polymerases tested, only HotStarTaq DNA Polymerase (in conjunction with Q-Sol
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Keys to Successful Densitometry
2. General Considerations for Successful Transfection Experiments
3. Designing a Successful qRT-PCR Experiment
4. Precursor miRNAs for Successful miRNA Functional Studies
5. Recommendations for Successful siRNA Library Screens
6. Setting up Successful siRNA Library Screens
7. Successful stabilization of gene expression profiles
8. The TripleMaster PCR System for three different amplifications
9. Advantages of Roche Applied Science amplification products
10. GenomiPhi: protocol for BAC amplification and fabrication of slides for array CGH
11. GenomiPhi amplification of FFPE tissue DNA for array CGH

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Successful PCR amplification and subcloning rich DNA fragment

(Date:11/24/2009)...SANDIEGO,Nov.24,2009/PRNewswire-FirstCall/--ArenaP...thatthecompanyisscheduledtopresentatthePiperJaffra...1:30a.m.EasternTime(8:30a.m.PacificTime)attheNewYo...ent andChiefExecutiveOfficer,isscheduledtoprovidea...entanddiscoveryprograms. ,, Aliveaudiowebcastof...
(Date:11/24/2009)...BOZEN,Italy,November24/PRNewswire/--HealthRobotics...turewithagroupofselected,investors.Thisrecentlyfor...lthRoboticsCanada,Inc.andwillmarket,install,andsup...chincludesthe,revolutionaryproductofferingsi.v.STA...nadaInc.willalsoprovideassistanceonan"asneeded,bas...
(Date:11/24/2009)... Chemical Abstracts Service (CAS)...ts that China,s patent office is now the world,s l...n chemistry. China trailed Japan,s patent office, ...), and the United States Patent and Trademark Offi...USPTO in 2005, WIPO in 2006, and exceeded Japan fo...
(Date:11/23/2009)...LAKE CITY, Nov. 23, 2009 In a provocative new stu...ing carbon dioxide emissions the major cause of g...ld,s economy collapses or society builds the equiv... "It looks unlikely that there will be any substa...cceleration in carbon dioxide emission rates," say...
Breaking Biology Technology:Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...Buinevicius, the first wave of streaming media was...ns in sports and entertainment; but by and large, ...media is now shifting from entertainment to being ... and the information experience. Just like the Int...tions and educational institutions are beginning t...
...isaster recovery techniques, such as off-site tape...ve full recovery, Ready Recovery provides nearly r...ystem mirroring technology, said Paul Shain, presi...om-built products based on best practices gathered...tion can help organizations reduce complexity in t...
... U.S. Representative Tammy Baldwin (D-WI) has anno...nding as part of the fiscal budget to the UW-Rock ...used to upgrade computers and lab equipment for st... and other healthcare related fields. , ,I know th...ntys economic development, Baldwin said. This scho...
Other Biology Technology:Congresswoman Baldwin secures Federal Funds for UW-Rock County 2
(Date:11/25/2009)... the heart pumps some 250 million liters of blood ...cle fibers of the heart have to be extremely durab...bauer, vice chair of the Department of Medicine II...f. Dr. H. A. Katus), has discovered a protein that...muscular unit, the sarcomere. In cooperation with ...
(Date:11/24/2009)...LRI) today named 12 new grant recipients for 2009....vative work across a broad spectrum of lupus resea...ty, and potential to drive scientific discovery to...isease of systemic lupus. , The 2009 grants go t...s the nation and include interdisciplinary and hig...
(Date:11/24/2009)...emarkable class of ring-shaped protein motors has ...rkeley National Laboratory (Berkeley Lab) using a ...at the Advanced Light Source (ALS). These protein ...eplication, and are vital to the survival of all b...h as the human papillomavirus, which has been link...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 1Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 2Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 3Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 4Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 1Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 2Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 3Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 4Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 5Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 6Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 7Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 8Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 9Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 10Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 11Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 12Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 13Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 14Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 15Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 16Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 17Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 18Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 19Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 20Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 21Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 22Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 23Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 24Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 25Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 26Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 27Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 28Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 29VIVUS Announces Promotion of Peter Tam to President 5941 1VIVUS Announces Promotion of Peter Tam to President 5941 2VIVUS Announces Promotion of Peter Tam to President 5941 3
...ence Foundation have launched a key initiative to ...ine; broadly defined as the development of stem ce...ells and tissues in the human body. , Stem cells ...en programmed to perform a specific function. Most...it is becoming clear that if these cells can be gi...
...letin Board: BMRX) a leading developer of finger r... the Handgun Club of America has endorsed the,Comp...g great interest in,bioMETRX,s smartTOUCH(TM) bioV...o stored firearms with the touch of a finger, and ...es can be used for controlled access,of handguns, ...
... Davis faculty member has resolved a longstanding ...ar more accurate predictions of global climate cha...lished online Wednesday (June 18) by the journal ...s of the nitrogen cycle in temperate and tropical ...capable of extracting nitrogen directly from the a...
Other Biology News:European Science Foundation aims to strengthen 'regenerative medicine' 2bioMETRX, Inc. Gun Storage Products Endorsed by the Handgun Club of America 2bioMETRX, Inc. Gun Storage Products Endorsed by the Handgun Club of America 3UC Davis researcher leads climate-change discovery 2
Human VEGFR2 (KDR), phospho ELISA development Kit, DuoSet IC Economy Pack from R&D Systems
Rabbit Anti-TAO2 Polyclonal Antibody, Unconjugated from R&D Systems
PEG 8000 Powder from Promega
Mouse Matrilin-4 from R&D Systems
Biology Products: